TP53 and non-small cell lung carcinoma: A panel of six antibodies (antibodies to p53, NY-ESO-1, CAGE, GBU4-5, Annexin 1 and SOX-2) was tested at the time of diagnosis of lung cancer on a cohort including both SCLC and NSCLC patients and matched controls.